New Enterprise Associates
http://www.nea.com/Home/New Enterprise Associates is a venture capital firm based in Baltimore, MD. The firm has backed more than 160 companies that have gone public and invested in more than 230 companies that have been successfully merged or acquired. NEA focuses its investments in the information technology, healthcare, and energy technology industries. While NEA makes a majority of its investments in the United States, the firm invests around the world in China and India. The firm was founded in 1978.
View Older Stories View More Recent Stories
-
Topia Launches New Solutions to Empower Organizations of All Sizes with Seamless Mobility Management
-
Ivantis Announces Settlement of Glaukos Patent Litigation
-
Beyond Identity Closes Software Supply Chain Vulnerability
-
Beyond Identity Closes Software Supply Chain Vulnerability
-
Aetion Welcomes Marla Kessler as First Chief Customer Officer To Accelerate Its Next Phase of Growth
-
Grant Thornton and Topia team to deliver tax offerings for remote and hybrid workforces
-
SIMBA Chain Raises $25 Million in Series A Funding
-
SIMBA Chain Raises $25 Million in Series A Funding
-
SIMBA Chain Raises $25 Million in Series A Funding
-
SIMBA Chain Raises $25 Million in Series A Funding
-
Lumos Pharma to Participate in September Investor Conferences
-
Lumos Pharma to Participate in September Investor Conferences
-
SIMBA Chain Raises $25 Million in Series A Funding
-
SIMBA Chain Raises $25 Million in Series A Funding
-
Databricks Raises $1.6 Billion Series H Investment at $38 Billion Valuation
-
Form SC 13D Robinhood Markets, Inc. Filed by: New Enterprise Associates 15, L.P.
-
Workera.ai Raises $16M in Funding Led by NEA to Close the Enterprise Skills Gap with Precision Upskilling Platform
-
Factbox-Investors are betting on rent-a-robot startups in Silicon Valley
-
CIT GAP Funds Invests in BloomCatch to Advance the Next Generation of Horticultural Expertise
-
CIT GAP Funds Invests in ArchiveCore to Simplify Healthcare Credentialing
-
First African American Elected Chair of TEDCO's Board of Directors
-
Form SC 13D Berkshire Grey, Inc. Filed by: New Enterprise Associates 15, L.P.
-
CIT GAP Funds Invests in ChowCall to Deliver Food and Goods to Military Communities
-
Jon Kondo Joins OmniSci as CEO To Drive Company Success in Accelerated Data Analytics
-
Study shows uninsured gig workers are unaware of affordable health insurance options
-
Lumos Pharma Reports Second Quarter 2021 Financial Results and Provides Clinical and Corporate Updates
-
Lumos Pharma Reports Second Quarter 2021 Financial Results and Provides Clinical and Corporate Updates
-
Form 4 Robinhood Markets, Inc. For: Aug 02 Filed by: New Enterprise Associates 17, L.P.
-
Metromile, Inc (MILE) Appoints John Butler and Sandra Clarke to its Board
-
Metromile Bolsters Board of Directors with Insurance and Finance Veterans
-
Metromile Bolsters Board of Directors with Insurance and Finance Veterans
-
Lumos Pharma, Inc. (LUMO) Announces Industry Veteran, David B. Karpf, MD, has Joined the Company as Chief Medical Officer
-
Lumos Pharma Announces Industry Veteran, David B. Karpf, MD, has Joined the Company as Chief Medical Officer
-
Lumos Pharma Announces Industry Veteran, David B. Karpf, MD, has Joined the Company as Chief Medical Officer
-
Lumos Pharma, Inc. (LUMO) Announces the Promotion of COO and Chief Scientific Officer, John McKew, PhD, to President
-
Lumos Pharma Announces the Promotion of COO and Chief Scientific Officer, John McKew, PhD, to President
-
Lumos Pharma Announces the Promotion of COO and Chief Scientific Officer, John McKew, PhD, to President
-
Syneos Health and Aetion Partner to Offer RWE Solutions to Advance Drug Development and Commercialization
-
Syneos Health and Aetion Partner to Offer RWE Solutions to Advance Drug Development and Commercialization
-
Form 3 Robinhood Markets, Inc. For: Jul 29 Filed by: New Enterprise Associates 17, L.P.
-
Lumos Pharma Appoints Pediatric Endocrinologist Experienced in Clinical Research and Pharmaceutical Development, Mark Bach, M.D., Ph.D., to Clinical Scientific Advisory Board
-
Lumos Pharma Appoints Pediatric Endocrinologist Experienced in Clinical Research and Pharmaceutical Development, Mark Bach, M.D., Ph.D., to Clinical Scientific Advisory Board
-
Reflecting on COVID-19 Innovation: Northwell Health Hosts Fourth Annual Constellation Forum
-
Form SC 13D Bright Health Group Inc. Filed by: New Enterprise Associates 17, L.P.
-
IonQ Positions Itself for Continued Industry Leadership with a String of Strategic Hires
-
Lumos Pharma to Report Second Quarter 2021 Financial Results and Host Conference Call on August 5, 2021
-
Lumos Pharma to Report Second Quarter 2021 Financial Results and Host Conference Call on August 5, 2021
-
Gig workers getting better health insurance at half the cost; 40% paying less than $1 per month.
-
Mobile And Web Brokerage Nvstr Rebrands As Tornado Empowering Smarter Investing Decisions For Anyone Who Aspires To Become A Better Investor
-
Lumos Pharma (LUMO) issues new guidance concerning the Phase 2 OraGrowtH210 Trial of LUM-201 in PGHD

